Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,251,148
-
Share change
-
+640,728
-
Total reported value
-
$22,106,288
-
Price per share
-
$1.45
-
Number of holders
-
48
-
Value change
-
+$1,518,178
-
Number of buys
-
26
-
Number of sells
-
16
Institutional Holders of AVEO PHARMACEUTICALS INC - COM (AVEO) as of Q1 2015
As of 31 Mar 2015,
AVEO PHARMACEUTICALS INC - COM (AVEO) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,251,148 shares.
The largest 10 holders included
Sarissa Capital Management LP, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, Gruss Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Deer VI & Co. LLC, Longwood Capital Partners LLC, GREYLOCK XI GP LIMITED PARTNERSHIP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.